Raymond James Financial Services Advisors, Inc. - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 32 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$13,000
-53.6%
48,6410.0%0.00%
Q2 2022$28,000
-3.4%
48,641
+11.5%
0.00%
Q1 2022$29,000
-38.3%
43,6410.0%0.00%
Q4 2021$47,000
-17.5%
43,6410.0%0.00%
Q3 2021$57,000
-34.5%
43,6410.0%0.00%
Q2 2021$87,000
-26.3%
43,6410.0%0.00%
Q1 2021$118,00043,6410.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$104,0000.08%
PERKINS CAPITAL MANAGEMENT INC 51,178$67,0000.04%
HATTON CONSULTING, INC. 27,195$35,0000.03%
GSA CAPITAL PARTNERS LLP 78,687$102,0000.01%
CRA Financial Services, LLC 19,957$26,0000.01%
Virtu Financial LLC 25,507$33,0000.00%
WEDBUSH SECURITIES INC 32,228$42,0000.00%
TWO SIGMA SECURITIES, LLC 15,347$20,0000.00%
UBS Group AG 13,118$17,0000.00%
US BANCORP \DE\ 9,047$12,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders